Advanced HNSCC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer (NCT04847466) | National Cancer Institute (NCI) | 2021-12-14 |
Track Advanced HNSCC automatically
Every clearance here is in the API, with alerts when new ones post.